Sara Crawford, Ph.D., Sheree L. Boulet, Dr.P.H., M.P.H., Allison S. Mneimneh, M.P.H., Kiran M. Perkins, M.D., M.P.H., Denise J. Jamieson, M.D., M.P.H., Yujia Zhang, Ph.D., Dmitry M. Kissin, M.D., M.P.H.
Volume 105, Issue 2, Pages 444-450
To assess treatment and pregnancy/infant-associated medical costs and birth outcomes for assisted reproductive technology (ART) cycles in a subset of patients using elective double ET and to project the difference in costs and outcomes had the cycles instead been sequential single ETs (fresh followed by frozen if the fresh ET did not result in live birth).
Retrospective cohort study using 2012 and 2013 data from the National ART Surveillance System.
US infertility treatment centers.
Fresh, autologous double ETs performed in 2012 among ART patients younger than 35 years of age with no prior ART use who cryopreserved at least one embryo.
Sequential single and double ETs.
Main Outcome Measure(s):
Actual live birth rates and estimated ART treatment and pregnancy/infant-associated medical costs for double ET cycles started in 2012 and projected ART treatment and pregnancy/infant-associated medical costs if the double ET cycles had been performed as sequential single ETs.
The estimated total ART treatment and pregnancy/infant-associated medical costs were $580.9 million for 10,001 double ETs started in 2012. If performed as sequential single ETs, estimated costs would have decreased by $195.0 million to $386.0 million, and live birth rates would have increased from 57.7%–68.0%.
Sequential single ETs, when clinically appropriate, can reduce total ART treatment and pregnancy/infant-associated medical costs by reducing multiple births without lowering live birth rates.
Read the full text at: http://www.fertstert.org/article/S0015-0282(15)02043-9/fulltext